American Century Companies’s Cue Biopharma CUE Stock Holding History

American Century Companies’s Portfolio CUE Stock Details CUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-725	Closed	-$50K	–	2887
2023 Q3	$50K	Buy	725 +323	+80%	+$31.5K	﹤0.01%	2804
2023 Q2	$44K	Buy	+402	New	+$47.2K	﹤0.01%	2771

Other funds holding CUE

SPC

Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

RSWM

Robertson Stephens Wealth Management San Francisco, California $3.57B AUM 28.36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

MAM

Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return

American Century Companies's CUE Position: Q4 2023 in Review

American Century Companies sold out of Cue Biopharma (CUE) in Q4 2023, closing a stake of 725 shares — an estimated $50K sold.

American Century Companies first reported a position in CUE in Q2 2023 and held it in 2 quarters. The position peaked at $50K in Q3 2023. 80 funds tracked by Wall St. Rank hold CUE as of Q4 2023.

American Century Companies reported no remaining Cue Biopharma position as of Q4 2023 after selling out during the quarter.
American Century Companies sold 725 Cue Biopharma shares in Q4 2023, an estimated $50K.
American Century Companies first reported a position in Cue Biopharma in Q2 2023 and held it in 2 quarters.
American Century Companies's Cue Biopharma position peaked at $50K in Q3 2023.
80 funds tracked by Wall St. Rank held Cue Biopharma as of Q4 2023.

Based on American Century Companies's 13F filing for Q4 2023, filed 13 Feb 2024.